1 / 1

Coleman, R. E. et al. (2013) Management of cancer treatment-induced bone loss

Figure 2 Changes in bone mineral density associated with treatment with goserelin and either tamoxifen (20 mg by mouth daily) or anastrozole

juliet
Download Presentation

Coleman, R. E. et al. (2013) Management of cancer treatment-induced bone loss

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 2 Changes in bone mineral density associated with treatment with goserelin and either tamoxifen (20 mg by mouth daily) or anastrozole (1 mg by mouth daily) for 36 months, with or without concomitant zoledronic acid (4 mg by intravenous infusion every 6 months) in premenopausal women with oestrogen-receptor-positive breast cancer Coleman, R. E. et al.(2013) Management of cancer treatment-induced bone loss Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2013.36

More Related